Notably, in our study, the dose of haloperidol that lowered levels of DAT in rat striatum would be viewed as being equivalent to a sub-clinical dose in humans45,46 and therefore may not be relevant to doses received by the patients with schizophrenia in this study. Here, SLC6A3 is linked to schizophrenia.